---
annotations:
- id: DOID:0080600
  parent: disease by infectious agent
  type: Disease Ontology
  value: COVID-19
- id: DOID:934
  parent: disease by infectious agent
  type: Disease Ontology
  value: viral infectious disease
- id: DOID:2945
  parent: disease by infectious agent
  type: Disease Ontology
  value: severe acute respiratory syndrome
- id: PW:0001308
  parent: disease pathway
  type: Pathway Ontology
  value: respiratory system disease pathway
- id: PW:0000003
  parent: signaling pathway
  type: Pathway Ontology
  value: signaling pathway
- id: DOID:3770
  type: Disease Ontology
  value: pulmonary fibrosis
authors:
- Penny
- Fehrhart
- Egonw
- Evelo
- Eweitz
- Ddigles
citedin:
- link: PMC9377275
  title: 'Identifying Drug-Induced Liver Injury Associated With Inflammation-Drug
    and Drug-Drug Interactions in Pharmacologic Treatments for COVID-19 by Bioinformatics
    and System Biology Analyses: The Role of Pregnane X Receptor (2022)'
- link: PMC9154116
  title: Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma
    patients (2022)
- link: PMC8891742
  title: AMP5A modulates Toll-like receptors 7 and 8 single-stranded RNA immune responses
    in PMA-differentiated THP-1 and PBMC (2022)
- link: PMC8821526
  title: Identification of Robust Protein Associations With COVID-19 Disease Based
    on Five Clinical Studies (2022)
- link: PMC8170012
  title: Systematic Organization of COVID-19 Data Supported by the Adverse Outcome
    Pathway Framework (2021)
- link: 10.1097/MD.0000000000033917
  title: Exploring the pharmacological mechanism of Duhuo Jisheng Decoction in treating
    intervertebral disc degeneration based on network pharmacology (2023)
- link: 10.1159/000529687
  title: Identification of the Genetic Influence of SARS-CoV-2 Infections on IgA Nephropathy
    Based on Bioinformatics Method (2023)
- link: 10.1371/journal.pone.0281981
  title: Identification of host genomic biomarkers from multiple transcriptomics datasets
    for diagnosis and therapies of SARS-CoV-2 infections (2023)
- link: 10.7554/eLife.91729.3
  title: Single-cell â€˜omic profiles of human aortic endothelial cells in vitro and
    human atherosclerotic lesions ex vivo reveal heterogeneity of endothelial subtype
    and response to activating perturbations (2024)
- link: 10.1016/j.bbrep.2023.101602
  title: Statistical and network analyses reveal mechanisms for the enhancement of
    macrophage immunity by manganese in Mycobacterium tuberculosis infection (2024)
- link: 10.1038/s41598-024-70629-7
  title: The differential expression of adipose tissue genes in short, medium and
    long-term periods after bariatric surgery (2024)
- link: 10.3390/v15030641
  title: Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2
    Spike Syncytial Formation and Anti-Inflammatory Effects (2023)
- link: PMC12230134
  title: Central nervous system and systemic inflammatory networks associated with
    acute neurological outcomes in COVID-19 (2025)
- link: PMC12106470
  title: 'Glypican-3 regulated epithelial mesenchymal transformation-related genes
    in osteosarcoma: based on comprehensive tumor microenvironment profiling (2025)'
communities:
- AOP
- COVID19
description: Experimental pathway to investigate overlap of Covid-19 downstream effects
  and adverse outcome pathways related to lung injury.
last-edited: 2025-07-09
ndex: ec7dd6ee-8b70-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4891
- /instance/WP4891
- /instance/WP4891_r139846
revision: r139846
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4891.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Experimental pathway to investigate overlap of Covid-19 downstream
    effects and adverse outcome pathways related to lung injury.
  keywords:
  - ACE2
  - AGT
  - CCL2
  - CCL3
  - CSF3
  - CXCL10
  - IL10
  - IL1B
  - IL2
  - IL2RA
  - IL6
  - IL7
  - IL8
  - TMPRSS2
  - TNF
  license: CC0
  name: COVID-19 adverse outcome pathway
seo: CreativeWork
title: COVID-19 adverse outcome pathway
wpid: WP4891
---